Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Efficacy and Safety of Low-Dose Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial

research Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial

January 2025 in “Annals of Dermatology”

Low-dose dutasteride effectively and safely promotes hair growth in men.

research The Rotterdam Study: 2018 update on objectives, design and main results

359 citations , September 2017 in “European Journal of Epidemiology”

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm

research Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm

5 citations , February 2024 in “Clinical Pharmacokinetics”

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

research Clinical Case Notes. Optical coherence tomography of adult-onset foveomacular vitelliform dystrophy

5 citations , February 2004 in “Clinical and Experimental Ophthalmology”

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

research Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata

23 citations , October 2024 in “British Journal of Dermatology”

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

research Effects of isotretinoin on the hair cycle

9 citations , October 2018 in “Journal of Cosmetic Dermatology”

Isotretinoin at a low dose for three months does not significantly affect hair growth.

research 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency

8 citations , January 1991 in “European Urology”

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Optimal Starting Dose of Clomiphene Citrate for Ovulation Induction in Anovulatory PCOS Women

research How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?

July 2023 in “Journal of Clinical Medicine”

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

research Ginseng for Health Care: A Systematic Review of Randomized Controlled Trials in Korean Literature

95 citations , April 2013 in “PLOS ONE”

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

research Building and Crossing the Translational Bridge: 2016 Alopecia Areata Research Summit Highlights

December 2017 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings”

The summit aimed to speed up finding treatments for alopecia areata.

← Previous page